Root Financial Partners
FHTX icon

Root Financial Partners’s Foghorn Therapeutics FHTX Stock Holding History

Root Financial Partners’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18 Buy
+5
New +$26 ﹤0.01% 3788
2026
Q2 		– Sell
-28
Closed -$134 – 1368
2026
Q1 		$134 Buy
+28
New +$154 ﹤0.01% 3230

Other funds holding FHTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Root Financial Partners's FHTX Position: Q3 2026 in Review

Root Financial Partners opened a new position in Foghorn Therapeutics (FHTX) in Q3 2026: 5 shares worth $18. The stake represents ﹤0.01% of the portfolio and ranks #3788 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in FHTX as recently as Q1 2026.

Root Financial Partners first reported a position in FHTX in Q1 2026 and has held it in 2 quarters since. The position peaked at $134 in Q1 2026. 44 funds tracked by Wall St. Rank hold FHTX as of Q3 2026.

  • Root Financial Partners held 5 shares of Foghorn Therapeutics worth $18 as of Q3 2026.
  • Foghorn Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Foghorn Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3788 holding.
  • Root Financial Partners first reported a position in Foghorn Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Root Financial Partners's Foghorn Therapeutics position peaked at $134 in Q1 2026.
  • 44 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.